The Centers for Disease Control and Prevention and the Food and Drug Administration on Tuesday announced they are pausing the Johnson & Johnson vaccine due to concerns of several rare blood clotting cases in individuals who have received the vaccine.
CDC and FDA pause Johnson & Johnson vaccine over rare blood clot concerns
